Th2 allergic immune response to inhaled fungal antigensis modulated by TLR-4-independent bacterial products

European Journal of Immunology

Volumn 39, Issue 3, 2009, Pages 776-788

  Allard, Jenna B ^a   Rinaldi, Lisa ^a   Wargo, Matthew J ^a   Allen, Gilman ^a   Akira, Shizou ^b   Uematsu, Satoshi ^b   Poynter, Matthew E ^a   Hogan, Deborah A ^c   Rincon, Mercedes ^a   Whittaker, Laurie A ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cytokines; Eosinophils; Immune responses; Lung inflammation; Th cells

Indexed keywords

BACTERIUM LYSATE; FUNGUS ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; CELL EXTRACT; CYTOKINE; IMMUNOLOGIC FACTOR; LIPOPOLYSACCHARIDE; MYD88 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHILIA; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; MALE; MOUSE; MUCUS SECRETION; NASOPHARYNGEAL ASPIRATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SQUAMOUS CELL METAPLASIA; TH1 CELL; TH2 CELL; ANIMAL; BACTERIUM; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; EOSINOPHIL; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; METAPLASIA; MICROBIOLOGY; MUCUS; PATHOLOGY; SECRETION;

ANIMALS; ANTIGENS, FUNGAL; ASPERGILLUS FUMIGATUS; BACTERIA; CANDIDA ALBICANS; CELL EXTRACTS; CYTOKINES; EOSINOPHILS; HYPERSENSITIVITY; IMMUNOLOGIC FACTORS; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG; MALE; METAPLASIA; MICE; MICE, INBRED C57BL; MUCUS; MYELOID DIFFERENTIATION FACTOR 88; NEUTROPHILS; PSEUDOMONAS AERUGINOSA; TH1 CELLS; TH2 CELLS; TOLL-LIKE RECEPTOR 4;

EID: 64049104440     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838932     Document Type: Article

References (79)

1. Cieslewicz, G., Tomkinson, A., Adler, A., Duez, C., Schwarze, J., Takeda, K., Larson, K. A. et al., The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J. Clin. Invest. 1999. 104: 301-308.
2. Ochkur, S. I., Jacobsen, E. A., Protheroe, C. A., Biechele, T. L., Pero, R. S., McGarry, M. P.,Wang, H. et al., Coexpression of IL-5 and eotaxin-2 inmice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. J. Immunol. 2007. 178: 7879-7889.
3. Shen, H. H., Ochkur, S. I., McGarry, M. P., Crosby, J. R., Hines, E. M., Borchers, M. T., Wang, H. et al., A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J. Immunol. 2003. 170: 3296-3305.
4. Chaplin, D. D., 1 Overview of the human immune response. J. Allergy Clin. Immunol. 2006. 117: S430-S435.
5. Allard, J. B., Poynter, M. E., Marr, K. A., Cohn, L., Rincon, M. and Whittaker, L. A., Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J. Immunol. 2006. 177: 5186-5194.
6. Portnoy, J. M., Barnes, C. S. and Kennedy, K., Importance of mold allergy in asthma. Curr. Allergy Asthma Rep. 2008. 8: 71-78.
7. Zeldin, Y., Kidon, M. I., Magen, E., Bibi, H., Cohen, A., Waisel, Y. and Kivity, S., Impact of specific allergen sensitization on the prevalence of asthma in patients with allergic rhinitis from adjacent distinct geographic areas. Ann. Allergy Asthma Immunol. 2008. 101: 30-34.
8. Pamer, E. G., Immune responses to commensal and environmental microbes. Nat. Immunol. 2007. 8: 1173-1178.
9. + T cell priming during respiratory fungal infection. Immunity 2006. 25: 665-675.
10. Hohl, T. M., Rivera, A. and Pamer, E. G., Immunity to fungi. Curr. Opin. Immunol. 2006. 18: 465-472.
11. Vandenbulcke, L., Bachert, C., Van Cauwenberge, P. and Claeys, S., The innate immune system and its role in allergic disorders. Int. Arch. Allergy Immunol. 2006. 139: 159-165.
12. Bauer, S., Hangel, D. and Yu, P., Immunobiology of toll-like receptors in allergic disease. Immunobiology 2007. 212: 521-533.
13. Renz, H., Blumer, N., Virna, S., Sel, S. and Garn, H., The immunological basis of the hygiene hypothesis. Chem. Immunol. Allergy 2006. 91: 30-48.
14. Moss, R. B., Pathophysiology and immunology of allergic bronchopulmonary aspergillosis. Med. Mycol. 2005. 43: S203-S206.
15. Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M. et al., Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am. J. Respir. Crit. Care Med. 2006. 173: 1114-1121.
16. Latzin, P., Fehling, M., Bauernfeind, A., Reinhardt, D., Kappler, M. and Griese, M., Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis. J. Cyst. Fibros. 2007. 7: 142-146.
17. Blumer, J. L., Saiman, L., Konstan, M. W. and Melnick, D., The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis. Chest 2005. 128: 2336-2346.
18. Anzueto, A., Sethi, S. and Martinez, F. J., Exacerbations of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2007. 4: 554-564.
19. Li, Z., Kosorok, M. R., Farrell, P. M., Laxova, A., West, S. E., Green, C. G., Collins, J. et al., Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005. 293: 581-588.
20. Sethi, S., Maloney, J., Grove, L., Wrona, C. and Berenson, C. S., Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006. 173: 991-998.
21. Tumkaya, M., Atis, S., Ozge, C., Delialioglu, N., Polat, G. and Kanik, A., Relationship between airway colonization, inflammation and exacerbation frequency in COPD. Respir. Med. 2007. 101: 729-737.
22. Kolls, J. K. and Linden, A., Interleukin-17 family members and inflammation. Immunity 2004. 21: 467-476.
23. Happel, K. I., Dubin, P. J., Zheng, M., Ghilardi, N., Lockhart, C., Quinton, L. J., Odden, A. R. et al., Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 2005. 202: 761-769.
24. Navarro, J., Rainisio, M., Harms, H. K., Hodson, M. E., Koch, C., Mastella, G., Strandvik, B. et al., Factors associated with poor pulmonary function: Cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Eur. Respir. J. 2001. 18: 298-305.
25. Doern, G. V. and Brogden-Torres, B., Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis. J. Clin. Microbiol. 1992. 30: 2740-2742.
26. Parameswaran, G. I. and Murphy, T. F., Infections in chronic lung diseases. Infect. Dis. Clin. North Am. 2007. 21: 673-695, viii.
27. Bulpa, P., Dive, A. and Sibille, Y., Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 2007. 30: 782-800.
28. Yasuo, M., Fujimoto, K., Tanabe, T., Yaegashi, H., Tsushima, K., Takasuna, K., Koike, T. et al., Relationship between calcium-activated chloride channel 1 and MUC5AC in goblet cell hyperplasia induced by interleukin-13 in human bronchial epithelial cells. Respiration 2006. 73: 347-359.
29. Kim, Y. K., Oh, S. Y., Jeon, S. G., Park, H. W., Lee, S. Y., Chun, E. Y., Bang, B. et al., Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J. Immunol. 2007. 178: 5375-5382.
30. Pier, G. B., Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunity. Int. J. Med. Microbiol. 2007. 297: 277-295.
31. Berger, M., Inflammatory mediators in cystic fibrosis lung disease. Allergy Asthma Proc. 2002. 23: 19-25.
32. Netea, M. G., Brown, G. D., Kullberg, B. J. and Gow, N. A., An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 2008. 6: 67-78.
33. Eisenbarth, S. C., Piggott, D. A., Huleatt, J. W., Visintin, I., Herrick, C. A. and Bottomly, K., Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 2002. 196: 1645-1651.
34. Altemeier, W. A., Matute-Bello, G., Gharib, S. A., Glenny, R. W., Martin, T. R. and Liles, W. C., Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J. Immunol. 2005. 175: 3369-3376.
35. Daubeuf, B., Mathison, J., Spiller, S., Hugues, S., Herren, S., Ferlin, W., Kosco-Vilbois, M. et al., TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock. J. Immunol. 2007. 179: 6107-6114.
36. Rodriguez, D., Keller, A. C., Faquim-Mauro, E. L., de Macedo, M. S., Cunha, F. Q., Lefort, J., Vargaftig, B. B. et al., Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J. Immunol. 2003. 171: 1001-1008.
37. Miller, S. I., Ernst, R. K. and Bader, M.W., LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 2005. 3: 36-46.
38. Aaron, S. D., Angel, J. B., Lunau, M., Wright, K., Fex, C., Le Saux, N. and Dales, R. E., Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001. 163: 349-355.
39. Harrison, F., Microbial ecology of the cystic fibrosis lung. Microbiology 2007. 153: 917-923.
40. Hurst, J. R. and Wedzicha, J. A., The biology of a chronic obstructive pulmonary disease exacerbation. Clin. Chest Med. 2007. 28: 525-536, v.
41. Mayer-Hamblett, N., Aitken, M. L., Accurso, F. J., Kronmal, R. A., Konstan, M. W., Burns, J. L., Sagel, S. D. et al., Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2007. 175: 822-828.
42. Sagel, S. D., Sontag, M. K., Wagener, J. S., Kapsner, R. K., Osberg, I. and Accurso, F. J., Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis. J. Pediatr. 2002. 141: 811-817.
43. Afessa, B., Morales, I. J., Scanlon, P. D. and Peters, S. G., Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure. Crit. Care Med. 2002. 30: 1610-1615.
44. Bulpa, P. A., Dive, A. M., Garrino, M. G., Delos, M. A., Gonzalez, M. R., Evrard, P. A., Glupczynski, Y. et al., Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med. 2001. 27: 59-67.
45. Murali, P. S., Pathial, K., Saff, R. H., Splaingard, M. L., Atluru, D., Kurup, V. P. and Fink, J. N., Immune responses to Aspergillus fumigatus and Pseudomonas aeruginosa antigens in cystic fibrosis and allergic bronchopulmonary aspergillosis. Chest 1994. 106: 513-519.
46. Ritz, N., Ammann, R. A., Casaulta Aebischer, C., Schoeni-Affolter, F. and Schoeni, M. H., Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis. Eur. J. Pediatr. 2005. 164: 577-582.
47. Hogan, D. A. and Kolter, R., Pseudomonas-Candida interactions: An ecological role for virulence factors. Science 2002. 296: 2229-2232.
48. Hogan, D. A., Vik, A. and Kolter, R., A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol. Microbiol. 2004. 54: 1212-1223.
49. Akagawa, G., Abe, S. and Yamaguchi, H., Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. J. Infect. Dis. 1995. 171: 1539-1544.
50. Burd, R. S., Raymond, C. S. and Dunn, D. L., Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection. J. Surg. Res. 1992. 52: 537-542.
51. Henry-Stanley, M. J., Hess, D. J., Erickson, E. A., Garni, R. M. and Wells, C. L., Effect of lipopolysaccharide on virulence of intestinal candida albicans. J. Surg. Res. 2003. 113: 42-49.
52. Chaudhuri, N., Whyte, M. K. and Sabroe, I., Reducing the toll of inflammatory lung disease. Chest 2007. 131: 1550-1556.
53. Greene, C. M. and McElvaney, N. G., Toll-like receptor expression and function in airway epithelial cells. Arch. Immunol. Ther. Exp. (Warsz) 2005. 53: 418-427.
54. Raymond, T., Schaller, M., Hogaboam, C. M., Lukacs, N. W., Rochford, R. and Kunkel, S. L., Toll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation. Proc. Am. Thorac. Soc. 2007. 4: 635-641.
55. Gomez, M. I. and Prince, A., Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr. Opin. Pharmacol. 2007. 7: 244-251.
56. Adamo, R., Sokol, S., Soong, G., Gomez, M. I. and Prince, A., Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am. J. Respir. Cell Mol. Biol. 2004. 30: 627-634.
57. Soong, G., Reddy, B., Sokol, S., Adamo, R. and Prince, A., TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J. Clin. Invest. 2004. 113: 1482-1489.
58. Doring, G., Obernesser, H. J., Botzenhart, K., Flehmig, B., Hoiby, N. and Hofmann, A., Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. J. Infect. Dis. 1983. 147: 744-750.
59. Kharazmi, A., Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa. Immunol. Lett. 1991. 30: 201-205.
60. Overhage, J., Bains, M., Brazas, M. D. and Hancock, R. E., Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J. Bacteriol. 2008. 190: 2671-2679.
61. Stepinska, M. and Trafny, E. A., Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines. Microb. Pathog. 2007. 44: 448-458.
62. Gacesa, P., Bacterial alginate biosynthesis--recent progress and future prospects. Microbiology 1998. 144: 1133-1143.
63. Morici, L. A., Carterson, A. J., Wagner, V. E., Frisk, A., Schurr, J. R., Honer zu Bentrup, K., Hassett, D. J. et al., Pseudomonas aeruginosa AlgR represses the Rhl quorum-sensing system in a biofilm-specific manner. J. Bacteriol. 2007. 189: 7752-7764.
64. Kheradmand, F., Kiss, A., Xu, J., Lee, S. H., Kolattukudy, P. E. and Corry, D. B., A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 2002. 169: 5904-5911.
65. Kiss, A., Montes,M., Susarla, S., Jaensson, E. A., Drouin, S. M.,Wetsel, R. A., Yao, Z. et al., A new mechanism regulating the initiation of allergic airway inflammation. J. Allergy Clin. Immunol. 2007. 120: 334-342.
66. Saijo, S., Fujikado, N., Furuta, T., Chung, S. H., Kotaki, H., Seki, K., Sudo, K. et al., Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 2007. 8: 39-46.
67. Taylor, P. R., Tsoni, S. V., Willment, J. A., Dennehy, K. M., Rosas, M., Findon, H., Haynes, K. et al., Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 2007. 8: 31-38.
68. Gersuk, G. M., Underhill, D. M., Zhu, L. and Marr, K. A., Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J. Immunol. 2006. 176: 3717-3724.
69. Hohl, T. M., Van Epps, H. L., Rivera, A., Morgan, L. A., Chen, P. L., Feldmesser, M., and Pamer, E. G., Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog. 2005. 1: E30.
70. Rivera, A., Van Epps, H. L., Hohl, T. M., Rizzuto, G. and Pamer, E. G., Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia. Infect. Immun. 2005. 73: 7170-7179.
71. Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M. et al., CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005. 307: 254-258.
72. Rahme, L. G., Stevens, E. J., Wolfort, S. F., Shao, J., Tompkins, R. G. and Ausubel, F. M., Common virulence factors for bacterial pathogenicity in plants and animals. Science 1995. 268: 1899-1902.
73. Fonzi, W. A. and Irwin, M. Y., Isogenic strain construction and gene mapping in Candida albicans. Genetics 1993. 134: 717-728.
74. Poynter, M. E., Irvin, C. G. and Janssen-Heininger, Y. M., A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. J. Immunol. 2003. 170: 6257-6265.
75. Dialynas, D. P., Quan, Z. S., Wall, K. A., Pierres, A., Quintans, J., Loken, M. R., Pierres, M. et al., Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK.15: Similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 1983. 131: 2445-2451.
76. Jones, B., Evidence that the Thy-1 molecule is the target for T cell mitogenic antibody against brain-associated antigens. Eur. J. Immunol. 1983. 13: 678-684.
77. Cohn, L., Homer, R. J., MacLeod, H., Mohrs, M., Brombacher, F. and Bottomly, K., Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J. Immunol. 1999. 162: 6178-6183.
78. Tomioka, S., Bates, J. H. and Irvin, C. G., Airway and tissue mechanics in a murine model of asthma: Alveolar capsule vs. forced oscillations. J. Appl. Physiol. 2002. 93: 263-270.
79. Hantos, Z., Daroczy, B., Suki, B., Nagy, S. and Fredberg, J. J., Input impedance and peripheral inhomogeneity of dog lungs. J. Appl. Physiol. 1992. 72: 168-178.